E7 via E2F also upregulates cyclin-dependent kinase inhibitor 2A (p16INK4A, or CDKN2A) expression, which acts as a prognostic biomarker for cervical cancer [40,41,42]. The gene discussed is CDKN2A; the disease is cervical carcinoma.